RESULTS OF MAZE PROCEDURE FOR TREATMENT OF ATRIAL FIBRILLATION USING RADIOFRIQUENCY ABLATION IN PATIENTS UNDERGOING MITRAL VALVE REPAIR OR BIOLOGICAL MITRAL VALVE REPLACEMENT
Main Article Content
Abstract
Objective: Evaluate the outcomes atrial fibrillation treatment with Maze procedure using radiofrequency ablation in patients undergoing mitral valve repair (MVR) or biological mitral valve replacement (BMVR). Subjects and methods: We described a series of cases. Results: There were 95 patients, mean of age was 62.3 ± 8.3 years. Men accounted for 52.6%. Palpitation was presented in 44.2% of cases. Maze procedure was performed in all patients. The in-hospital mortality rate was 1.1%, 14.7% of patients suffered from early complications. The average follow-up time was 24.3 ± 14.2 months. At the endpoint of follow-up, there were 3 patients who died and 5 patients who had permanent pacemakers implantation. The rate of freedom from AF at first month, 3rd month, 6th month, 12th month and the end of the study was 82.9%, 73.4%, 76.6%, 84.8%, 82.9% and 72.6%, respectively. Conclusion: Maze procedure using radiofrequency ablation in patients undergoing MVR or BMVR was safe and effective with a high rate of sinus rthythm restoration.
Article Details
Keywords
Atrial fibrillation, Mitral valve repair, Biological mitral valve replacement, Maze procedure
References
2. Abdulla, J. and J.R. Nielsen, Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis. Europace, 2009. 11(9): p. 1156-9.
3. Otto, C.M., et al., 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 2021. 143(5): p. e35-e71.
4. Fan, X., et al., Mitral valve repair and concomitant maze procedure versus catheter ablation in the treatment of atrial functional mitral regurgitation. BMC Cardiovasc Disord, 2022. 22(1): p. 543.
5. Meinertz, T., et al., Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry. Clin Res Cardiol, 2011. 100(10): p. 897-905.
6. January, C.T., et al., 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation, 2019. 140(2): p. e125-e151.
7. Kim, J.B., et al., Mitral valve replacement with or without a concomitant Maze procedure in patients with atrial fibrillation. Heart, 2010. 96(14): p. 1126-31.
8. Ad, N., et al., Long-term outcome following concomitant mitral valve surgery and Cox maze procedure for atrial fibrillation. J Thorac Cardiovasc Surg, 2018. 155(3): p. 983-994.